William M Oldham MD PhD
Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine
Assistant Professor, Harvard Medical School and Associate Physician, Brigham and Women's Hospital
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-7420
Fax+1 617-582-6102
Dr. Oldham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Oldham is a pulmonologist in Boston, MA and is affiliated with multiple hospitals in the area, including Newton-Wellesley Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Faulkner Hospital. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 9 years. He specializes in critical care medicine, pleural disease, and pulmonary vascular medicine and is experienced in pulmonary hypertension, pulmonology, critical care medicine, internal medicine, and pulmonary vascular disease.
Education & Training
Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2014- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2010
Vanderbilt University School of MedicineClass of 2008
Vanderbilt UniversityPhD, Pharmacology, 2006
Certifications & Licensure
MA State Medical License 2010 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsMechano-dependent sorbitol accumulation supports biomolecular condensate.Stephanie Torrino, William M Oldham, Andrés R Tejedor, Ignacio S Burgos, Lara Nasr
Cell. 2025-01-23 - 1 citationsLeukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosis.Hung N Nguyen, Yunju Jeong, Yunhye Kim, Mari Kamiya, Yaunghyun Kim
Proceedings of the National Academy of Sciences of the United States of America. 2024-12-10 - Diverse NKT cells regulate early inflammation and neurological outcomes after cardiac arrest and resuscitation.Tomoyoshi Tamura, Changde Cheng, Ana B Villaseñor-Altamirano, Kohei Yamada, Kohei Ikeda
Science Translational Medicine. 2024-12-04
Press Mentions
Exercise Intolerance and Low Cardiac Filling Pressures in a Woman with a Novel eNOS MutationSeptember 27th, 2024
Meet the First AuthorsMarch 15th, 2018- Multi-Omics Characterization of Partial Chemical Reprogramming Reveals Evidence of Cell RejuvenationMarch 28th, 2024
Grant Support
- Role of lactate transporters in pulmonary fibrosisBRIGHAM AND WOMEN'S HOSPITAL2023–2028
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
